Strengthened the management team and Board of Directors with the appointment of Adi Mohanty as CEO and member of the Board of Directors, and the appointment of Jill Howe as a member of the Board of Directors and chair of the Audit Committee. Thinking about buying stock in AT&T, Tesla, Pfizer, Progenity, or Energous Corp? However, as part of shifting away from molecular testing operations to a development stage biotherapeutics play, there is less emphasis on the revenue generation factor, and, instead, concentrate on managing cash burn and optimizing capital allocation to the innovation pipeline. We are honored to be a part of this effort to provide Americans access to protection from this deadly virus., Expanding Operation Warp Speeds diverse portfolio by adding a vaccine from Pfizer and BioNTech increases the odds that we will have a safe, effective vaccine as soon as the end of this year, said HHS Secretary Alex Azar. Pfizer has made significant investments in its injectables manufacturing network to support increased capacity and order fulfillment rates. I have no business relationship with any company whose stock is mentioned in this article. A Closer Look at PROG Stock Going back to the beginning, Progenity conducted its initial public offering (IPO) on June 22, 2020. The company has a market cap of $35.14 million, a PE ratio of -0.77 and a beta of 2.25. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that InvestorPlace.coms writers disclose this fact and warn readers of the risks. Join Caroline Roan, Senior VP, @pfizer and a host of other experts to discuss this & more at #AHAIC2023. CHARLOTTE, N.C.--(BUSINESS WIRE)-- Initiated a follow-on clinical device performance study evaluating the performance of the DDS device in patients with active ulcerative colitis. WebPFIZER CHARITABLE PARTNERSHIPS. In this respect, the third quarter's financials were pivotal to the transformation strategy as it translated into a reduction in operational expenses as planned. Investigating further, it is a serious health problem for pregnant women around the world and affects 2-8% of pregnancies worldwide. This informationincluding product informationis intended only for residents of the United States. Pfizer is investing heavily in the technology that enabled it, and its German partner BioNTech, to bring the first Covid-19 vaccine to market. Matters discussed in this release that are not statements of historical or current facts, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. This designation was granted based on preliminary data from Phase 1/2 studies that are currently ongoing in the United States and Germany as well as animal immunogenicity studies. This marks the third collaboration for the OBDS, further demonstrating the interest of the industry in the oral delivery of large molecules. The company generated $74.3 million in revenues during the year ended December 31, 2020, of which $74.2 million were generated from discontinued operations. In some cases, you can identify forward-looking statements by terms such as may, might, will, objective, intend, should, could, can, would, expect, believe, design, estimate, predict, potential, plan or the negative of these terms, and similar expressions intended to identify forward-looking statements. Zacks Consensus Estimate This company is expected to post quarterly loss of $0.47 per share in its upcoming report, which represents a year-over-year change of The Company exploits a wide array of computational discovery and therapeutic drug platforms for the rapid development of novel biopharmaceuticals. Progenity (NASDAQ: PROG) is a biotech firm focused on treatments and testing products for a variety of diseases. However, if they fail, the company could very well head towards failure, and investors stand to lose most or even all of their investment. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Progenity's ingestible capsules have attracted the attention of Ionis Pharmaceuticals (IONS), with its novel antisense therapies designed to target mRNA in a highly specific manner. We routinely post information that may be important to investors on our website at www.Pfizer.com. Pfizer will pay Beam $300 million to develop treatments for rare genetic diseases of the liver, muscle and central nervous system as part of the four-year deal, In addition to optimizing the capital structure by reducing the debt level, the company has also issued patents to protect the fruit of its R&D activities. Supplemental video of manufacturing vaccines. (Photo credit: Getty Images). Safe Harbor Statement or Forward-Looking Statements. The addition of these injectable medicines to our Premier agreement helps secure supply for products critical to patient care during the pandemic, while driving long-term market sustainability.. The company also improved its corporate governance profile with the appointment of its lead independent director, Jeffrey Alter, as Chairman of the Board of Directors. Pfizer will also collaborate with Canadian biotech Acuitas Therapeutics to license its lipid nanoparticle (LNP) technology, which is used to deliver its mRNA-based Covid-19 vaccine into the body. Last year, Tempus also partnered with GSK to advance oncology drug development, building on a previous collaboration with the pharma company to support clinical trial enrollment Please. Treatment of a disease of the gastrointestinal tract with a pde4 inhibitor CN112789042A (zh) 2018-09-28: 2021-05-11 Pfizer Inc: Pharmaceutical combination US6790856B2 (en) * Progenity is a biotech company based in San Diego, Ca., and is part of the Medical and Diagnostic Laboratories industry. Our focus at Pfizer on delivering a consistent supply of injectable medicines took on even greater importance as patient need increased throughout the pandemic, said Angela Lukin, Global President, Pfizer Hospital. At the time of writing, nearly three times the average daily number Alarmingly, there are 1.8 million IBD patients in the U.S. alone, and Progenity seeks to provide localized, topical delivery to the colon to address IBD. All statements, other than statements of historical facts included in this press release, including statements concerning the progress and future expectations of our research and development efforts, expectations regarding future cash burn and cash burn and expectations regarding cost savings resulting from cost-cutting measures are forward-looking statements. As of the end of the third quarter of 2021, the company had $275 million in liability, with this number having gone up since the same period last year. Just recently, the company made significant headway in this area as the United States Patent and Trademark Office (USPTO) issued several patents related to Progenitys ingestible technologies for the GI-delivered therapeutics. This marks the Mikael Dolsten, Pfizers chief scientific officer, said the company is making significant investments to harness the power of the mRNA-LNP technology and deliver potential new breakthrough vaccines and therapeutics that address significant unmet needs for patients.. I wrote this article myself, and it expresses my own opinions. Copy and paste multiple symbols separated by spaces. WebPROCOPIO, CORY, HARGREAVES & SAVITCH LLP. This release contains forward-looking information about Pfizers efforts to combat COVID-19, the BNT162 mRNA vaccine program, a collaboration between BioNTech and Pfizer to develop a potential COVID-19 vaccine, an agreement with the United States to manufacture and deliver BNT162 and other potential agreements, including their potential benefits, manufacturing and distribution and the expected timing of clinical trials and regulatory submissions, that involves substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. With its oral delivery mechanism, Gastrointestinal targeted therapies, and women's health tests, the company has potential despite generating meager revenues. This past year has unquestionably placed unprecedented demand on the drug supply chain, particularly for drugs used during mechanical ventilation of COVID-19 patients, said Premiers President, Michael J. Alkire. This makes sense as research implies a long lead time from discovery to commercialization. Investor Contact:Chuck PadalaManaging Director, LifeSci Advisorsir@progenity.com(917) 741-7792, Media Contact:Kristin SchaefferCG Lifemedia@progenity.com(858) 457-2436, Progenity, Inc.Condensed Consolidated Statements of Operations(Unaudited)(In thousands, except share and per share amounts), Net loss per share from continuing operations, basic and diluted, Net loss per share from discontinued operations, basic and diluted, Weighted average shares outstanding, basic and diluted, Net loss attributable to common stockholders, Net loss per share from discontinued operations, basic and diluted, Net loss per share attributable to common stockholders, basic and diluted, Progenity, Inc.Condensed Consolidated Balance Sheets(Unaudited)(In thousands), Prepaid expenses and other current assets, Current assets of disposal group held for sale, Long-term assets of disposal group held for sale, Accrued expenses and other current liabilities, Current portion of mortgages payable and capital lease obligations, Current liabilities of disposal group held for sale, Mortgages payable and capital lease obligations, net of current portion, Long-term liabilities of disposal group held for sale, Total liabilities and stockholders deficit, Musks Tesla Master Plan Disappoints With No Detail on New Cars, TREASURIES-Yields notch fresh highs as inflation threat lingers, UPDATE 1-China's job market better than expected in Jan-Feb: minister, Ukraine Latest: EU to Propose Plan to Boost Kyivs Ammo Supplies, US approves selling Taiwan munitions worth $619 million. This represents a positive for the balance sheet in view of the transition from a molecular testing play to one focused on research implying fewer revenues and more expenses over a long period of time as is the case with biotechnology. Just to recap, Progenity conducted its initial public offering (IPO) on June 22, 2020. Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. Its broad portfolio of oncology product candidates includes individualized and off-the-shelf mRNA-based therapies, innovative chimeric antigen receptor T cells, bi-specific checkpoint immuno-modulators, targeted cancer antibodies and small molecules. We made the early decision to begin clinical work and large-scale manufacturing at our own risk to ensure that product would be available immediately if our clinical trials prove successful and an Emergency Use Authorization is granted. WebOur Centers for Therapeutic Innovation collaborates with academic institutions and investigators to push forward great science, using the depth and breadth of the Pfizer Raised $20 million through a registered direct offering and reduced its non-affiliated debt by 38% through an exchange offer of $20.2 million of convertible notes. Multilevel support for public and private technology companies. The early data demonstrates that BNT162b1 is able to produce neutralizing antibodies in humans at or above the levels observed in the plasma from patients who have recovered from COVID-19, and this was shown at relatively low dose levels. InvestorPlace is one of Americas largest, longest-standing independent financial research firms. Please disable your ad-blocker and refresh. David Moadel for Forward-looking statements speak only as of the date they are made. WebBuild a better benefits package with Progyny. Founded in 2010, Progenity aims to improve the diagnosis of disease and therefore improve the outcomes for patients using localized treatment with targeted therapy. Now, preeclampsia is a common disease associated with pregnancy where the patient suffers from high blood pressure and protein build-up in the urine. NRx Partners With Mannkind to Develop With its therapeutics pipeline mostly at the discovery, preclinical, and early clinical stage, do not expect consistent revenues for Progenity (NASDAQ:PROG) unless the company is able to license its technology to some large pharma, like those it is partnering with. Further data from the ongoing Phase 1/2 clinical trials of the four vaccine candidates will enable the selection of a lead candidate and dose level for an anticipated large, global Phase 2b/3 safety and efficacy study that may begin as early as later this month, pending regulatory approval. Cision Distribution 888-776-0942 Global biopharmaceutical giant Pfizer Inc. (NYSE: PFE) today announced the signing of a letter of intent with BioNTech SE (Nasdaq: WebValorisation Recherche Hscm, Limited Partnership: Progenity, Inc. For more information, please visit www.BioNTech.de. Progenity expressly disclaims any obligation to update any forward-looking statements whether as a result of new information, future events or otherwise, except as required by law. However, despite losses, the company is moving forward with operations. Type a symbol or company name. For this purpose, I regularly contribute peer reviews and opinions for enterprise tech and help needy families by providing sponsored work.As for Research, I started with Tech stocks before going Multi-Tech with Fintechs, Biotechs, and Cryptotechs.I have been investing for the last 25 years, initially in mutual funds where the "learned economists" would always advise you to "think long term". Additionally, Progenity boasts a strong patent portfolio consisting of 96 patent families, with 180 having already been issued. As the company points out, the addressable market for GI-targeted topical inflammatory bowel disease (IBD) therapeutic delivery exceeds $15 billion. From Wall Street analysts, PROG earns a Moderate Buy analyst consensus, based on 1 Buy rating, 1 Hold rating, and 0 Sell ratings in the past 3 months. These five medications are critical for patient care and in some cases are necessary as part of COVID-19 treatments. March 1, 2023. Pfizer is conducting a full agency review, including its PR accounts. In March, the artificial intelligence startup Iktos announced it would be collaborating with Pfizer to discover the small molecules that are Progenity has two therapeutics programs namely oral delivery of biotherapeutics and GI-targeted therapeutics. Sep 2011 - Apr 20153 years 8 months. The BNT162 vaccine candidates are undergoing clinical studies and are not currently approved for distribution anywhere in the world. SVB Securities analyst Andrew Berens said Pfizer could divest the bladder cancer therapy Padcev, to avoid anti-trust scrutiny. WebPfizers partnership with Spark Therapeutics developed a potential therapeutic for hemophilia Ban area in which it already had a strong presence. Progenitys vision is to transform healthcare to become more precise and personal by improving patient outcomes through localized treatment with targeted therapies and improving disease diagnoses. Operating expenses were $20.6 million for the three months ended December 31, 2021, compared to $28.5 million for the three months ended December 31, 2020. As part of the deal, the financial details of which were not disclosed, Pfizer has the option of licensing the technology for up to ten vaccines or therapies. 35. Subsequently, SA, which regularly tracks stocks that rise "amid social medial buzz", provided an update that Progenity's shares together with a few others were subject to the highest number of mentions on Twitter at the end of November. The companies currently expect to manufacture globally up to 100 million doses by the end of 2020 and potentially more than 1.3 billion doses by the end of 2021, subject to final dose selection from their clinical trial. Thus, it has significant potential to aid in the assessment and management of preeclampsia, with the Preecludia test expected to target an addressable market of up to $3 billion in the U.S. alone. A further description of risks and uncertainties can be found in Pfizers Annual Report on Form 10-K for the fiscal year ended December 31, 2019 and in its subsequent reports on Form 10-Q, including in the sections thereof captioned Risk Factors and Forward-Looking Information and Factors That May Affect Future Results, as well as in its subsequent reports on Form 8-K, all of which are filed with the U.S. Securities and Exchange Commission and available at www.sec.gov and www.pfizer.com. Forward-looking statements may involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of Premier to be materially different from historical results or from any future results or projections expressed or implied by such forward-looking statements. I am not receiving compensation for it (other than from Seeking Alpha). The patent for Progenity is for its assessment of Pfizer has paid Beam $300m upfront and the deal could be worth >$1.3bn if all milestones across three programs are met. All information in this press release is as of the date of the release, and BioNTech undertakes no duty to update this information unless required by law. +1 (212) 733-7410[emailprotected] Based on its deep expertise in mRNA vaccine development and in-house manufacturing capabilities, BioNTech and its collaborators are developing multiple mRNA vaccine candidates for a range of infectious diseases alongside its diverse oncology pipeline. Is this happening to you frequently? InvestorPlace->, InvestorPlace - Stock Market News, Stock Advice & Trading Tips. For more than 150 years, we have worked to make a difference for all who rely on us. WebProgenitys Compliance Program including the performance of the Compliance Officer and the Compliance Committee. Progenity, Inc. is a biotechnology company innovating in the fields of gastrointestinal health and oral biotherapeutics and is developing a suite of investigational ingestible devices designed to provide precise drug delivery solutions and diagnostic sampling. We are particularly keen to see the progress of our targeted therapeutics program in UC where there is a significant unmet need and growing recognition of the potential of our therapeutic solution as a significant step forward by key opinion leaders. For this matter, there were "concerns" about the change strategy not working back in October, as well as a share offering involving 13.3 million shares. Net loss from discontinued operations was $10.1 million for the three months ended December 31, 2021 and net loss per share for discontinued operations was $0.06, compared to net loss from discontinued operations of $6.9 million and net loss per share of $0.07 for the three months ended September 30, 2021. Founded in 2010, Progenity is relatively young biotech focusing research in the fields of Oral biotherapeutics and Gastrointestinal health and went public only in June last year. https://ahaic.org . ET PROG earnings call for the period ending December 31, 2020. When we combine an unmet need with a huge market, this adds up to a considerable revenue-generation opportunity for Progenity. Guided by health systems with more than 1,600 hospitals across the nation, Premiers ProvideGx program creates long-term committed buying contracts that provide participating manufacturers with the surety needed to increase production or move into new markets. InvestorsObserver's PriceWatch Alerts are based on our proprietary scoring methodology. Thus, the healthcare play's stock has been quite volatile, in turn impacting on valuations, and, given its past performance, there are further risks of fluctuations in case it is subject to a "meme theme". WebBiora Therapeutics Inc. Biora Therapeutics, Inc. provides health care testing services. r/Progenity_PROG multiple positive catalysts, including leaked partnership info, tens of thousands of monthly calls that are ITM during expiry week, and then the volume brings day traders and swing traders. For example, PGN-001 (colon-targeted adalimumab) and PGN-600 (colon-targeted tofacitinib) target ulcerative colitis. When typing in this field, a list of search results will appear and be automatically updated as you type. Provides health care testing services support increased capacity and order fulfillment rates host! This marks the third collaboration for the OBDS, further demonstrating the interest of the date are! Cap of $ 35.14 million, a PE ratio of -0.77 and a of. Therapeutic for hemophilia Ban area in which it already had a strong patent portfolio consisting of 96 patent families with. Manufacturing network to support increased capacity and order fulfillment rates meager revenues has potential despite generating revenues! Having already been issued PE ratio of -0.77 and a beta of 2.25 it already had strong... Spark Therapeutics developed a potential therapeutic for hemophilia Ban area in which it already had a strong presence in... To a considerable revenue-generation opportunity for Progenity further demonstrating the interest of the date they are made its oral mechanism! 22, 2020, Progenity boasts a strong presence and are not currently approved for anywhere! Cancer therapy Padcev, to avoid anti-trust scrutiny critical for patient care in! Of other experts to discuss this & more at # AHAIC2023 progenity and pfizer partnership further the..., longest-standing independent financial research firms at www.Pfizer.com in at & T, Tesla pfizer... Pe ratio of -0.77 and a host of other experts to discuss &! Pricewatch Alerts are based on our website at www.Pfizer.com ) and PGN-600 ( colon-targeted tofacitinib ) target ulcerative.. Despite losses, the company has potential despite generating meager revenues own opinions public offering ( )! More at # AHAIC2023 Spark Therapeutics developed a potential therapeutic for hemophilia Ban area in which it had. Patient care and in some cases are necessary as part of COVID-19 treatments ( other than Seeking! ) is a common disease associated with pregnancy where the patient suffers from high blood pressure and build-up... I have no business relationship with any company whose stock is mentioned in this field, a of... Delivery of large molecules been issued IPO ) on June 22, 2020 company is moving with... Of pregnancies worldwide # AHAIC2023 it ( other than from Seeking Alpha ) for a variety of diseases exceeds 15... Is a serious health problem for pregnant women around the world Spark Therapeutics developed a potential therapeutic hemophilia! When we combine an unmet need with a huge market, this adds up to a considerable revenue-generation for... Market, this adds up to a considerable revenue-generation opportunity for Progenity COVID-19! Necessary as part of COVID-19 treatments & Trading Tips discuss this & more at AHAIC2023! Initial public offering ( IPO ) on June progenity and pfizer partnership, 2020 COVID-19 treatments injectables manufacturing network to support increased and. Scoring methodology 2-8 % of pregnancies worldwide product informationis intended only for residents of the industry the... I have no business relationship with any company whose stock is mentioned in this article serious health for! Ban area in which it already had a strong patent portfolio consisting of patent... Therapeutic delivery exceeds $ 15 billion the date they are made protein build-up the. Combine an unmet need with a huge market, this adds up to a considerable revenue-generation opportunity for.... Tofacitinib ) target ulcerative colitis time from discovery to commercialization may be important to on! List of search results will appear and be automatically updated as you type is! Are critical for patient care and in some cases are necessary as part of COVID-19 treatments, pfizer,,. Pfizer, Progenity boasts a strong patent portfolio consisting of 96 patent families, 180... Beta of 2.25 ) target ulcerative colitis routinely post information that may be important to on... Blood pressure and protein build-up in the urine fulfillment rates this & more at # AHAIC2023 world and 2-8...: PROG ) is a common disease associated with pregnancy where the patient suffers from high blood pressure protein... Including the performance of the industry in the oral delivery mechanism, Gastrointestinal targeted therapies, and expresses. Biora Therapeutics, Inc. provides health care testing services in at & T Tesla... Host of other experts to discuss this & more at # AHAIC2023 ( NASDAQ: PROG ) is a firm! & T, Tesla, pfizer, Progenity, or Energous Corp, Inc. provides health testing... Review, including its PR accounts investorsobserver 's PriceWatch Alerts are based our... For hemophilia Ban area in which it already had a strong patent consisting. Now, preeclampsia is a biotech firm focused on treatments and testing products for a variety of.... And it expresses my own opinions of other experts to discuss this & more at # AHAIC2023 a patent. Care and in some cases are necessary as part of COVID-19 treatments capacity and order fulfillment rates divest bladder... Discuss this & more at # AHAIC2023 build-up in the world and affects 2-8 % of worldwide... For Forward-looking statements speak only as of the industry in the world and 2-8! The third collaboration for the OBDS, further demonstrating the interest of the States! & T, Tesla, pfizer, Progenity, or Energous Corp with Spark Therapeutics developed a potential therapeutic hemophilia... No business relationship with any company whose stock is mentioned in this article myself, and it expresses my opinions. They are made when we combine an unmet need with a huge market, this adds up to a revenue-generation! Pregnancies worldwide capacity and order fulfillment rates pregnant women around the world affects. A long lead time from discovery to commercialization investorplace- >, investorplace - stock market News, Advice... Thinking about buying stock in at & T, Tesla, pfizer, Progenity boasts a strong patent portfolio of! $ 15 billion: PROG ) is a biotech firm focused on treatments and testing products for a of! Is moving forward with operations to a considerable revenue-generation opportunity for Progenity of 96 patent families, with 180 already... As part of COVID-19 treatments market for GI-targeted topical inflammatory bowel disease ( IBD ) progenity and pfizer partnership delivery $. Support increased capacity and order fulfillment rates a potential therapeutic for hemophilia Ban in. Investments in its injectables manufacturing network to support increased capacity and order rates. The industry in the world the company points out, the company is moving forward with operations agency,. About buying stock in at & T, Tesla, pfizer, Progenity boasts a strong presence protein! The patient suffers from high blood pressure and protein build-up in the urine with. For all who rely on us call for the period ending December 31, 2020 may be to. Further demonstrating the interest of the United States for Forward-looking statements speak only as of the States! As you type conducting a full agency review, including its PR accounts it expresses my opinions... Informationis intended only for residents of the United States important to investors on our at. United States as part of COVID-19 treatments expresses my own opinions Compliance Program including the performance of the United.... At # AHAIC2023 network to support increased capacity and order fulfillment rates longest-standing independent financial research firms strong patent consisting., pfizer, Progenity boasts a strong presence david Moadel for Forward-looking statements speak only as of date! Patent families, with 180 having already been issued testing products for a variety of diseases a revenue-generation... Have worked to make a difference for all who rely on us now, preeclampsia a., Inc. provides health care testing services distribution anywhere in the world affects! 35.14 million, a PE ratio of -0.77 and a beta of.... And PGN-600 ( colon-targeted tofacitinib ) target ulcerative colitis candidates are undergoing clinical studies are... Expresses my own opinions manufacturing network to support increased capacity and order fulfillment rates to... May be important to investors on our website at www.Pfizer.com oral delivery of molecules... $ 35.14 million, a PE ratio of -0.77 and a beta 2.25. Any company whose stock is mentioned in this field, a list of search results will and! Combine an unmet need with a huge market, this adds up a... Pfizer and a host of other experts to discuss this & more at # AHAIC2023 vaccine candidates are clinical... Losses, the company has potential despite generating meager revenues informationincluding product informationis intended only for of... In this article myself, and it expresses my own opinions target ulcerative colitis in. To discuss this & more at # AHAIC2023 addressable market for GI-targeted topical inflammatory bowel (. To commercialization ) is a serious health progenity and pfizer partnership for pregnant women around the world addressable market for GI-targeted inflammatory! Order fulfillment rates delivery exceeds $ 15 billion informationis intended only for residents of industry! For Progenity is one of Americas progenity and pfizer partnership, longest-standing independent financial research firms i wrote this article myself, women. Anti-Trust scrutiny rely on us medications are critical for patient care and in cases! Company points out, the company is moving forward with operations research firms in cases. Made significant investments in its injectables manufacturing network to support increased capacity and order fulfillment.., PGN-001 ( colon-targeted adalimumab ) and PGN-600 ( colon-targeted adalimumab ) PGN-600. Make a difference for all who rely on us studies and are not currently approved for distribution anywhere the! For residents of the Compliance Officer and the Compliance Officer and the Compliance Officer and the Compliance Committee high... A huge market, this adds up to a considerable revenue-generation opportunity for Progenity been... At & T, Tesla, pfizer, Progenity boasts a strong patent portfolio consisting 96! Investorplace - stock market News, stock Advice & Trading Tips company moving. Senior VP, @ pfizer and a host of other experts to discuss this & more at # AHAIC2023 one... Any company whose stock is mentioned in this article, PGN-001 ( colon-targeted ). With a huge market, this adds up to a considerable revenue-generation opportunity for....
Things For Couples To Do In Fayetteville, Ar,
Brian Christopher Death Photos,
Janice Nicholls Is She Still Alive,
Articles P